TY  - GEN
AU  - Smith,Matthew R
AU  - Egerdie,Blair
AU  - Hernández Toriz,Narciso
AU  - Feldman,Robert
AU  - Tammela,Teuvo L J
AU  - Saad,Fred
AU  - Heracek,Jiri
AU  - Szwedowski,Maciej
AU  - Ke,Chunlei
AU  - Kupic,Amy
AU  - Leder,Benjamin Z
AU  - Goessl,Carsten
TI  - Denosumab in men receiving androgen-deprivation therapy for prostate cancer
SN  - 1533-4406
PY  - 2009///0827
KW  - Aged
KW  - Aged, 80 and over
KW  - Androgen Antagonists
KW  - adverse effects
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - Bone Remodeling
KW  - Denosumab
KW  - Double-Blind Method
KW  - Fractures, Bone
KW  - epidemiology
KW  - Gonadotropin-Releasing Hormone
KW  - agonists
KW  - Humans
KW  - Incidence
KW  - Injections, Subcutaneous
KW  - Lumbar Vertebrae
KW  - Male
KW  - Middle Aged
KW  - Orchiectomy
KW  - Osteoporosis
KW  - chemically induced
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - RANK Ligand
KW  - Spinal Fractures
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa0809003
ER  -